A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Veliparib (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 21 Jan 2017 Trial design presented at the 2017 Gastrointestinal Cancers Symposium
- 14 Oct 2016 Status changed from not yet recruiting to recruiting.